FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:762-763 February 20, 2003 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Levey, A. S. PubMed Citation

To the Editor: In his Clinical Practice article (Nov. 7 issue)¹ Dr. Levey states, "If an ACE [angiotensin-converting–enzyme] inhibitor is contraindicated because of cough or angioedema, then an angiotensin-receptor blocker would be a logical alternative." Although an angiotensin-receptor blocker would be a logical and safe alternative for someone with an ACE-inhibitor–related cough, the same cannot be said about someone who has previously had angioedema due to the use of an ACE inhibitor.

There have been several reports of angioedema induced by the use of an angiotensin-receptor blocker in patients who had previously had angioedema while taking an ACE inhibitor. The . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.